TERROSA 20 micrograms/80 microlitres, solution for injection cartridge, 2.4 ml, CIP 3400930198209
Active ingredients: TÉRIPARATIDE
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectioncartridge, 2.4 ml, CIP 3400930198209sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TERROSA 20 microgrammes/80 microlitres, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 cartouche(s) en verre siliconé(e) suremballée(s)/surpochée(s) de 2,4 ml
- Marketing authorisation holder
- GEDEON RICHTER ( HONGRIE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68681263CIP73019820CIP133400930198209Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TÉRIPARATIDEsolution | 20 microgrammes · 80 microlitres | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.